Comparing Nypozi vs Romiplostim
| Nypozi (filgrastim) | Romiplostim |
|
|---|
| Nypozi (filgrastim) | Romiplostim |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Bone Marrow Transplantation, Hematopoietic Syndrome of Acute Radiation Syndrome, Neutropenia Associated with Radiation... View more |
Prescription only
Prescribed for Immune Thrombocytopenia, Thrombocytopenia, Hematopoietic Syndrome of Acute Radiation Syndrome. Romiplostim may also be used for purposes not listed in this medication guide. |
Related suggestions Hematopoietic Syndrome of Acute Radiation Syndrome
|
|||||||
| More about Nypozi (filgrastim) | More about Romiplostim | ||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Romiplostim has an average rating of 7.8 out of 10 from a total of 13 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Nypozi side effects |
View all Romiplostim side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Nypozi prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other filgrastim brands include: Neupogen, Nivestym, Releuko, Zarxio | Nplate | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
5.8 hours |
816 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 175 drugs are known to interact with Nypozi:
|
A total of 9 drugs are known to interact with Romiplostim:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
June 28, 2024 |
August 22, 2008 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Diflucan
Diflucan (fluconazole) is used to treat and prevent fungal infections. Includes Diflucan side ...
Zarxio
Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Neupogen
Neupogen (filgrastim) is used to treat neutropenia, a lack of certain white blood cells caused by ...
Nivestym
Nivestym is used for bone marrow transplantation, neutropenia, neutropenia associated with ...
Fulphila
Fulphila is used for febrile neutropenia, neutropenia associated with chemotherapy
Udenyca
Udenyca is used for febrile neutropenia, hematopoietic syndrome of acute radiation syndrome ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.